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Amblygonocarpus andongensis (family: Mimosaceae) is ethnomedicinally used in Northern Nigeria for 
the relief of pain. The methanolic extract of the plant stem bark was evaluated for anti-nociceptive 
activity using acetic acid-induced writhing model and formalin test in mice. Anti-inflammatory property 
was tested on egg albumin-induced oedema in rats while agar dilution method was used for 
antimicrobial effect. The acute toxicity effect (LD50) was also determined via intraperitoneal route. The 
results showed the LD50 value to be 547.7 mg/kg i.p. There was a significant (P < 0.05) dose-dependent 
reduction of acetic acid-induced pain at 50, 100, 200 mg/kg i.p. The extract at the same doses 
significantly (P < 0.05) inhibited pains in both early and late phases of the formalin test. However, the 
extract showed neither anti-inflammatory nor anti-microbial effects. The results corroborate the folkloric 
use of the plant. 
 






Amblygonocarpus andongensis (Mimosaceae) is widely 
spread in tropical Africa, mostly in the Savannah areas. It 
is a tree usually 30–40 feet high, but reaching 60 feet and 
5 feet girth in moist areas with a wide flat open crown. 
The bole is clean and straight. The bark is grey to brown, 
rough, flaking off in irregular patches leaving reddish 
scars; slash dark brown, crumbly lighter beneath (Keay et 
al., 1964). The leaves are mostly at the ends of the erect 
twig and entirely glabrous with leaflets pale-blue-green. 
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The fruits are dark brown, 4–5 inches long by about 1 
inch across, hanging on thick stalks 2–3 inches long 
(Keay et al., 1964). From the ethnobotanical knowledge 
of traditional medicine in Adamawa State, Northern 
Nigeria, an infusion of the bark is taken to relieve pains in 
the breast. The objective of this study was to establish 
the scientific basis on which this claim is made. 
 
 
MATERIALS AND METHODS 
 
Plant collection and extraction 
 
The stem bark was collected from Adamawa State, Northern 
Nigeria in July 2001. The identification of the plant was carried out 





of the plant was air-dried and grounded to powder in a mortar with 
the pestle. 375 g of the powdered material was cold macerated in 1 
L of methanol at 25°C for 24 h. The sample was then suction-
filtered through Whatman #1 filter paper. The filtrate was then 
evaporated to near dryness with a rotary evaporator at 90–100°C to 
give a dark brownish crude extract. The crude extract was brought 





Swiss Albino mice (22.1–28.2 g) and Wistar rats (208.3–220.0 g) of 
both sexes were used for the studies. The animals were bred in the 
Animal Facility Centre (AFC), Department of Pharmacology and 
Toxicology, National Institute for Pharmaceutical Research and 
Development (NIPRD), Abuja, Nigeria. The animals were 
maintained under normal environmental conditions. They were fed 
ad libitum with standard feed (Ladokun Feeds PLC, Ibadan, 
Nigeria) and water from the Abuja Municipal Area Council except 





Glacial acetic acid (Searle, Essex, England), formaldehyde 40% w/v 
(M & B, England), triton X-100 (GE Healthcare, UK), nutrient agar 





The microorganisms used in this study include Pseudomonas 
aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 13709), 
Escherichia coli (ATCC 9637), Candida albicans (ATCC 10231), 
Klebsiella pneumoniae, Proteus mirabilis, Bacillus subtilis and 
Salmonella typhi all of which were clinically isolated, standardized 
and stored by the Department of Microbiology, Human Virology and 
Biotechnology, National Institute for Pharmaceutical Research and 
Development (NIPRD), Abuja, Nigeria. 
 
 
Acute toxicity study 
 
This involves the estimation of the median lethal dose (LD50), which 
is the dose that will kill 50% of the animal population within 24 h 
post treatment with the extract. The method of Lorke (1983) was 
modified and used. Swiss Albino mice were starved of feed but 
allowed access to water 24 h prior to the study and were then 
grouped (four mice per group). They were treated intraperitoneally 
with different doses of the extract (500, 600, 700, 800, 900, 1000, 
1500 mg/kg). The animals were then observed for 24 h for any 
behavioural effects such as nervousness, excitement, dullness, in-
coordination or even death. The LD50 was estimated from the 
geometric mean of the dose that caused 100% mortality and the 
dose, which caused no lethality at all. 
 
 
Acetic acid-induced writhing in mice 
 
The study was carried out according to the method of Siegmund et 
al. (1957) as modified by Koster et al. (1959). The mice were 
grouped into four (of five mice each). Three different groups of mice 
were pre-treated with the extract at doses of 50, 100 and 200 mg/kg 
i.p., respectively. The fourth group of mice received normal saline 
(10 ml/kg i.p.). 10 ml/kg of 0.75 % glacial acetic acid was then 
administered intraperitoneally to every mouse 30, 60, 90 and 120 
min post extract/normal saline treatment. Each mouse was placed 
in a transparent observation box. 5 min post acetic acid administra- 




tion, the number of abdominal constrictions (writhes) made within 
the next 5 min by every mouse was counted using a manual table 
counter.  The percentage of the writhes for every time interval (30, 
60, 90, 120 min) was calculated as follows: 
 
Writhes (%) = (Test mean for every interval/Control mean for the 
same interval) x 100 
 
Also, the percentage dose-effect of the extract on the abdominal 
constriction was calculated thus; 
 
Dose-effect (%) = (Total abdominal constrictions per dose/Total 
abdominal constrictions for control group) x 100 
 
The difference between 100 and the calculated percent abdominal 
constriction is considered to be the dose-pain inhibition effect (%) of 
the extract. The values were all compared statistically with the 





The modified method of Dubuisson and Dennis (1977) was adopted 
for this study. Four groups of mice (of five mice each) was given the 
extract (50, 100, 200 mg/kg i.p.) and normal saline (10 ml/kg i.p.), 
respectively. 30 min post treatment, 50 l of 2.5% formalin was 
injected into the sub-plantar surface of the left hind paw of every 
mouse. The severity of pain exhibited by every mouse was 
observed and rated as scores:  
 
0 = mice walked or stood firmly on the injected paw 
1 = partially elevated the paw from the floor 
2 = elevated the paw without contact with the floor 
3 = licked, bit or shook the paw 
 
These observations were recorded every 2 min for the first 10 min 
(early phase) and at every 5 min between the 10 and 60 min 





The extract was tested for its ability to inhibit or suppress 
inflammation using fresh egg albumin-induced oedema model in 
rats. This was in accordance with the technique of Winter et al. 
(1962) as modified by Akah and Nwambie (1994). Both male and 
female rats used for the investigation were fasted overnight. They 
were deprived of water during the experiment to ensure uniform 
hydration and to minimize variability in edematous response (Winter 
et al., 1963). The rats were separated into groups (of five rats each) 
and were treated with the extract (25, 50, 100 mg/kg i.p.) and 
normal saline (10 ml/kg i.p.), respectively. 30 min post treatment, 
inflammation was induced by injecting 0.1 ml of fresh egg albumin 
(phlogistic agent) into the sub-plantar surface of the right hind paw 
of the rats. The measurement of the paw volume (cm3) was done 
on the principle of volume displacement using LETICA Digital 
Plethysmometer (LE 7500) which was earlier calibrated with 0.1 % 
Triton X-100. The readings were taken before and at 20 min 
intervals after the injection of egg albumin for a period of 2 h. The 
oedema at every interval was calculated in relation to the paw 





The agar dilution method of Jonas et al. (1989) was employed to 
determine the antimicrobial activity. Nutrient agar was prepared 
according to the manufacturer’s instruction while the extract (4 mg)  

































Figure 1.  The dose-pain inhibition effects of A. andongensis stem bark on glacial acetic acid-induced 




was dissolved in 1 ml of sterile distilled water to give an extract 
concentration of 4 mg/ml. The later solution was then diluted with 
19 ml of the prepared nutrient agar to provide a required 
concentration of 2000 g/ml. Each of the test organisms was 
cultured overnight in nutrient broth to approximately 5 X 107 to 9 X 
107 cfu/ml. A 1:20 dilution of the later was then made in normal 
saline for inoculation. Surface streaking of each innoculum was 
done on the extract-containing nutrient agar plate using a wire loop 
with a capacity of 0.002 ml. The organisms were also streaked on 
plates containing only nutrient agar (organism viability control) and 
on plates containing nutrient agar and sterile distilled water, which 
also served as the control. The plates were kept overnight in an 






All the results were expressed as mean ± SEM. The significance of 
difference between the control and treated groups were determined 
using two-way analysis of variance (ANOVA), followed by Student t-





Acute toxicity study 
 
All the mice became dull within 10–15 min post extract 
administration. However, only mice treated with doses  
600 mg/kg i.p died within 24 h of treatment. The median 
lethal dose (LD50) was estimated to be 547.7 mg/kg i.p. 
 
 
Acetic acid-induced writhing in mice 
 
The stem bark extract of A. andongensis (50, 100, 200 
mg/kg i.p.) significantly (P < 0.05) reduced the degree of 
acetic acid-induced abdominal constrictions in mice at all 
doses and at every interval. The dose-pain reduction 
effect of the extract was calculated to be 80.3, 82.0 and 
86.7% for the 50, 100 and 200 mg/kg i.p groups, 
respectively. This shows a dose-dependent reduction of 
acetic acid-induced pain (Figure 1). The study revealed 
anti-nociceptive effect of the extract from the period of 30 
to 120 min. However, the maximal anti-nociceptive 
effects for 100 and 200 mg/kg i.p doses were seen at the 
60 min having writhing of 5.22 and 0.00 % (i.e. percent 
inhibition of writhes of 94.8 and 100.0 %), respectively 
(Figure 2). The values were all significantly (P < 0.05) 





The study revealed that the stem bark extract of A. 
andongensis had a significant (P < 0.05) activity in both 
the early (0–10 min) and late (15–60 min) phases of the 
formalin test. In the early phase, the activities were seen 
to be higher with decreasing doses. In this phase, the 
doses of 200, 100 and 50 mg/kg i.p showed a mean 
severity of pain of 4.8 ± 2.9, 4.3 ± 0.9 and 2.5 ± 1.0, 
respectively. In the late phase however, the activity was 
least with the lowest dose of 50 mg/kg showing mean 
severity of pain of 12.8 ± 5.4 as against 7.8 ± 2.9 and 8.3 
± 2.3 for 100 and 200 mg/kg i.p doses, respectively. All 
the values were significant (P < 0.05) compared with the 





The stem barks extract of A. andongensis (25, 50, 100 
mg/kg i.p.)  did not  suppress or inhibit fresh egg albumin- 
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Figure 2.  The time effect of methanolic extract of A. andongensis stem bark on glacial acetic acid-induced 




Table 1. Effect of methanolic extract of A. andongensis stem bark on early and late phases of formalin-induced pain in mice. 
 
Early Phase Late Phase Treatment  
Group (n = 5) Score of pain ± SEM % Inhibition Score of pain ± SEM % Inhibition 
Normal saline (10 ml/kg i.p.) 11.00 ± 1.0 - 18.75 ± 3.2 - 
A. andongensis  (Mg/kg i.p.) 
50 2.50 ± 1.0*** 77.27 12.75 ± 5.4 32.00** 
100 4.25 ± 0.9*** 61.36 7.75 ± 2.9 58.67* 
200 4.75 ± 2.9* 56.82 8.25 ± 2.3 56.00*** 
 




induced inflammation in rats (P > 0.05). The statistical 






The methanolic extract (2000 g/ml) did not show 
antimicrobial activity against in all the test organisms 





The present study revealed some of the pharmacological 
basis for the ethnomedicinal use of stem bark of A. 
andongensis in pain relief. Acetic acid-induced abdominal 
constriction model adopted for anti-nociceptive study is a 
sensitive method in detecting analgesic effect of 
medicinal agents. It is able to detect anti-nociceptive 
effect of compounds/dose levels that may be inactive in 
other methods like the tail-flick test (Collier et al., 1968; 
Bentley et al., 1981). The mechanism for the abdominal 
constriction is postulated to partly involve local peritoneal 
receptors (Bentley et al., 1983) caused by peritoneal fluid 
concentration of PGE2 and PGF2 (Deraedt et al., 1980). 
The extract showed a significant dose-dependent 
reduction in the number of acetic acid-induced writhes in 
mice. This probably means that the extract is able to 
reduce the receptor sensitivity to the chemically (acetic 
acid)-induced pain in a dose-dependent manner. This 
therefore shows anti-nociceptive activity. 
This result was further corroborated by the formalin test 
results. According to Dubuisson and Dennis (1977) and 
Tjølsen et al. (1992), the nociception induced by formalin 
occurs in two distinct phases. The early phase represents 
the phasic pain while the late phase represents the tonic 
pain. The first phase ensues immediately after formalin 
injection and continues for 5 min, after which nociception  



























Control Ext. 25 mg/kg Ext. 50 mg/kg Ext. 100 mg/kg
 
 




appears to diminish. In the second phase, nociception 
returns to high levels beginning 15–20 min after formalin 
injection and continuing for ~ 60 min. The first phase is 
believed to be a direct result of stimulation of nociceptors 
in the paw while the second phase may reflect the 
inflammation process and at least to some degree, the 
sensitization of central nociceptive neurons (Coderre et 
al., 1990; Coderre and Melzack, 1992).  
The present study revealed that the extract showed 
activity on both the early and late phase of nociception. 
This did not only support the anti-nociceptive activity of 
the extract but also depicted its possible mechanisms of 
action. Tjølsen et al. (1992) reported that formalin test 
method is useful for elucidating the mechanism of pain 
and analgesia. Drugs which act mainly centrally such as 
narcotics, inhibit both phases of formalin-induced pain, 
while drugs such as aspirin, hydrocortisone and 
dexamethasone which are primarily peripherally acting, 
only inhibit the late phase (Chen et al., 1995; Elisabetsky 
et al., 1995; Santos et al., 1995). The activity of the 
extract on both early and late phases of pain therefore 
suggests the possible involvement of the central 
mechanism in the pain inhibition. Also, the late phase of 
formalin test involves peripheral inflammatory process 
and since the extract was able to inhibit this phase 
involving inflammation, it might also mean an involvement 
of the peripheral mechanism in anti-nociceptive effect. 
However, the later assumption of involvement of the 
peripheral mechanism may not be true since anti-
inflammatory study carried out showed that the extract at 
the tested doses of 25, 50, 100 mg/kg i.p did not reduce 
egg albumin-induced inflammation in rats. This method is 
an in vivo model of inflammation used to screen agents 
for acute inflammatory effect (Akah et al., 1993; Akah and 
Nwambie, 1994; Amos et al., 2002). 
Some drugs are known to have clinically effective 
analgesic and anti-inflammatory properties. This is well 
documented for various non-steroidal anti-inflammatory 
drugs (NSAIDs) especially with salicylates and their 
congeners (Reuse, 1978; Beuoist and Misse, 1979; 
Famaey, 1983). Others are potent anti-inflammatory 
agents but lack or have only weak analgesic properties; 
such includes phenylbutazone (Insel, 1996). Some are 
however effective analgesics, but lack significant anti-
inflammatory properties, e.g. phenacetin, acetaminophen 
(Insel, 1996). The extract therefore belongs to the later 
classification since it showed anti-nociceptive activity and 
no anti-inflammatory effect. 
The intraperitoneal median lethal dose of the extract 
estimated to be 547.7 mg/kg probably suggests that the 
extract may not have a wide safety margin. Lorke (1983) 
considered LD50 values > 1000 mg/kg body weight as 
being safe. This therefore means that care needs to be 
taken on the frequency and dose of intake of the stem 
bark infusion. It is possible that cumulative toxic effects 
may occur if the extract is taken over time. Some reports 
have shown the need for sub-chronic data in the 
prediction of hazards of long term, low dose exposure to 
a particular compound (McNamara, 1976). Also worth 
noting is the dullness observed in the treated mice in the 
acute toxicity study. This probably confirms the sugges-
ted central activity mechanism of anti-nociception. The 
lack of microbial growth inhibition observed in the anti-





not susceptible to its activity or that the extract does not 
have antimicrobial activity at all. However, it is possible 
that other microorganisms may be susceptible to the 
effects of the plant extract. 
In conclusion, these studies have shown that the stem 
bark extract of A. andongensis contains some active 
principles with the potentials of being good analgesics. 
This was demonstrated in its ability to inhibit pain in both 
acetic acid-induced writhing and formalin tests. These 
results conform to the folkloric use of the plant and also 
revealed its potential for the development of putative 
herbal analgesic remedies. Efforts are ongoing to 
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